^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

IGF1 elevation

i
Other names: IGF1, IGF-I, IGF1A, IGFI, Insulin-like growth factor 1, somatomedin C
Entrez ID:
Related biomarkers:
10d
Construction and validation of a risk prediction model for postoperative lung infection in elderly patients with lung cancer. (PubMed, Medicine (Baltimore))
Age > 70 years, smoking history, diabetes history, prolonged use of perioperative antibiotics, and elevated CRP, IL-6, and IGF-1 levels on the 1st day after surgery have an impact on postoperative lung infection in elderly patients with LC. Early postoperative monitoring of changes in CRP, IL-6, and IGF-1 levels can provide an important reference for predicting the occurrence of postoperative lung infections.
Retrospective data • Journal
|
IL6 (Interleukin 6) • IGF1 (Insulin-like growth factor 1) • CRP (C-reactive protein)
|
IL6 elevation • IGF1 elevation
21d
Ectopic acromegaly with tumoral range hyperprolactinemia and apoplexy with a dramatic regression of pituitary hyperplasia. (PubMed, Front Endocrinol (Lausanne))
Histopathology was suggestive of a neuroendocrine tumor, with immunohistochemistry positive for GHRH and negative for prolactin. Her final diagnosis was ectopic acromegaly due to GHRH secreting a lung NET with pituitary somatotroph and lactotroph pituitary hyperplasia and apoplexy in the hyperplastic pituitary.
Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
1m
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling. (PubMed, Cell Death Dis)
Additionally, TAMs/CXCL1 silence improved paclitaxel chemosensitivity by suppressing autophagy in breast cancer mice xenografts, and clinical studies further linked CXCL1 to IGF1R/HMGB1 signaling, as well as shorter free survival of recurrence. Taken together, these results not only uncover the crucial role of TAMs/CXCL1 signaling in mediating breast cancer chemoresistance through enhancing autophagy, but also shed novel light on the molecular mechanism of IGF1R/STAT3/HMGB1 pathway in regulating autophagy and its impact on cancer prognosis.
Journal
|
HMGB1 (High Mobility Group Box 1) • CXCL1 (Chemokine (C-X-C motif) ligand 1)
|
IGF1 elevation
|
paclitaxel
1m
A Case of Nonislet Cell Tumor Hypoglycemia Due to Metastatic Salivary Myoepithelial Carcinoma. (PubMed, AACE Clin Case Rep)
A 63-year-old female with a past medical history of metastatic salivary MECA, type 2 diabetes mellitus previously on metformin, hypertension, and hypothyroidism presented to her oncologist for chemotherapy and was found to have a serum glucose of 30 mg/dL (reference: 65-99)...This case demonstrates that NICTH can be associated with metastatic salivary MECA. The hypoglycemia in this scenario is challenging to manage and is associated with poor prognosis.
Journal • Metastases
|
IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2)
|
IGF1 elevation • IGF2 elevation
|
metformin
2ms
Insulin-like growth factor-1 deficiency caused by hepatocellular adenoma leads to growth arrest, primary amenorrhea and metabolic syndrome: a case report and 4 years follow up. (PubMed, BMC Endocr Disord)
We provide evidence that liver-derived IGF-1 has a direct effect on skeletal and pubertal development, blood pressure, visceral adiposity and dyslipidemia independent of insulin resistance and obesity in the circumstance of undernutrition. Though rare, we propose the need to look into HCA cases for the existence of IGF-1 deficiency and its impact on metabolic derangement.
Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
7ms
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly (clinicaltrials.gov)
P=N/A, N=20, Active, not recruiting, Cedars-Sinai Medical Center | Recruiting --> Active, not recruiting | Trial completion date: Dec 2023 --> Apr 2025 | Trial primary completion date: Dec 2023 --> Apr 2025
Enrollment closed • Trial completion date • Trial primary completion date
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
8ms
Acromegaly among a Moroccan population. (PubMed, Pan Afr Med J)
This study shows the complex management of acromegaly. Disease control is a necessary condition in order to avoid complications, but is often difficult to obtain.
Retrospective data
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
9ms
The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer. (PubMed, Int J Mol Sci)
Our findings demonstrate the presence and activity of the IGF system in the local tumor ecosystem, which is likely a characteristic feature of malignant disease and plays a role in its peritoneal dissemination. The potential clinical implications are supported by our finding that serum levels of the proteins are associated with patient prognosis.
Journal
|
IGF1 (Insulin-like growth factor 1) • PAPPA2 (Pappalysin 2) • IGF2 (Insulin-like growth factor 2) • STC2 (Stanniocalcin 2) • STC1 (Stanniocalcin 1)
|
IGF1 elevation
9ms
U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study. (PubMed, Front Endocrinol (Lausanne))
There was a U-shaped trend between IGF-1 and new-onset NAFLD in patients with PitNET. Further evaluation of our discoveries is warranted.
Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
9ms
Diabetes Mellitus and Thyroid Cancers: Risky Correlation, Underlying Mechanisms and Clinical Prevention. (PubMed, Diabetes Metab Syndr Obes)
This article reviews the latest research progress on the relationship between thyroid cancer and diabetes, including the association between diabetes and the risk of developing thyroid cancer, its underlying mechanisms, and potential anti-thyroid cancer effects of hypoglycemic drugs. It providing novel strategies for the prevention, treatment, and improving the prognosis of thyroid cancer.
Review • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
9ms
Acromegalic Rat Model Presented Cognitive Impairments and Tau Hyperphosphorylation in Hippocampus. (PubMed, Neuroendocrinology)
The prolonged elevation of GH and insulin-like growth factor 1 (IGF-1) levels caused by acromegaly may lead to abnormalities in the SD rat's PI3K-Akt-GSK3β signaling pathway, subsequently resulting in hyperphosphorylation of hippocampal tau protein and cognitive impairment.
Preclinical • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
9ms
IGF-1R mediates crosstalk between nasopharyngeal carcinoma cells and osteoclasts and promotes tumor bone metastasis. (PubMed, J Exp Clin Cancer Res)
The intricate interplay among IGF-1R, IGF-1, and GM-CSF highlights potential therapeutic targets for precise control of NPC bone metastasis, providing valuable insights for developing targeted interventions.
Journal
|
CSF2 (Colony stimulating factor 2)
|
IGF1 elevation
|
sirolimus • NVP-AEW541
9ms
Circulating Adipocytokines and Insulin Like-Growth Factors and Their Modulation in Obesity-Associated Endometrial Cancer. (PubMed, Cancers (Basel))
Lastly, it is noteworthy that a discernible inverse relationship trend was observed in the levels of adipocytokines and IGFs 6 months post-surgery. This indicates that treatment for endometrial cancer may have a differential impact on adipocytokines and IGFs, potentially holding clinical significance that merits further investigation.
Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2) • LEP (Leptin)
|
IGF1 elevation • IGF2 elevation
10ms
The Dairy and Cancer Controversy: Milking the Evidence. (PubMed, Curr Oncol Rep)
Available data suggests that a diet emphasizing fiber-rich foods such as whole grains, fruits, and vegetables, while restricting milk and dairy intake-similar to the Mediterranean dietary pattern-might mitigate cancer incidence. However, further research is crucial to elucidate the precise role of dairy products in overall cancer risk.
Review • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
12ms
Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly. (PubMed, Front Endocrinol (Lausanne))
Measurement of both GH and IGF-I remains an essential component of diagnosis and monitoring the effectiveness of treatment in acromegaly; however, treatment goals based only on previously identified absolute thresholds are not appropriate without taking into account the assay and reference ranges being employed. Treatment goals should be individualized considering biochemical improvement from an untreated baseline, symptoms of disease, risks, burdens and costs of complex treatment regimens, comorbidities, and quality of life.
Review • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
1year
Circulating levels of FoxP3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients. (PubMed, J Immunoassay Immunochem)
Elevated serum levels of sCD163, FoxP3 and IGF-1 are associated with the diagnosis of LSCC. IGF-1 appears to be the most promising indicator for the LSCC progression.
Journal
|
IGF1 (Insulin-like growth factor 1) • FOXP3 (Forkhead Box P3)
|
IGF1 elevation
1year
Recurrent Non-islet Cell Tumor Hypoglycemia Secondary to Hepatocellular Carcinoma: Case Report and Literature Review. (PubMed, Z Gastroenterol)
Early recognition and diagnosis of NICTH are crucial in patients with recurrent hypoglycemia and large tumors. Surgical resection is the preferred treatment option, but supportive care and pharmacological interventions, such as glucocorticoids and growth hormone, can help manage refractory hypoglycemia. Further research is needed to explore novel treatment options, including anti-IGF-I and -IGF-II neutralizing antibodies.
Review • Journal
|
IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2)
|
IGF1 elevation
1year
Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study. (PubMed, Endocrine)
The risk of malignancies, especially thyroid cancer, was increased in patients with acromegaly in our center. More cancer screening should be considered when managing acromegaly, especially in patients with higher posttreatment GH and IGF-1.
Retrospective data • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
1year
Synergism of Carbamoylated Erythropoietin and Insulin-like Growth Factor-1 in Immediate Early Gene Expression. (PubMed, Life (Basel))
We also examined which kinase signaling pathways might be mediating these effects and found that while AKT inhibition did not alter the pattern of IEG expression, both ERK and JAK2 inhibition significantly decreased IEG expression. These results begin to define the molecular effects of combining CEPO and IGF-1 and indicate the potential for these trophic factors to produce positive, synergistic effects.
Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
1year
Elevated IGF-1 concentrations in children with low grade glioma: A descriptive analysis in a retrospective national cohort. (PubMed, J Neuroendocrinol)
Elevated IGF-1 seems to be related to hypothalamic dysfunction worsening over time. Larger prospective cohort studies are needed.
Retrospective data • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
1year
Insulin-like growth factor 1 receptor inhibits the proliferation of acute myeloid leukaemia cells via NK cell activation. (PubMed, Ann Hematol)
Additionally, elevated IGF1R expression promotes NK cell expansion and enhances its functional activation, thereby inhibiting AML cell proliferation. Collectively, these findings highlight the clinical potential of IGF1R in the effective treatment of AML through the activation of NK cell proliferation and function and suggest that it may represent a potential predictive marker of AML prognosis.
Journal • IO biomarker
|
IGF1R (Insulin-like growth factor 1 receptor)
|
IGF1R expression • IGF1 elevation
over1year
Position statement on the diagnosis and management of acromegaly: the French National Diagnosis and Treatment Protocol (NDTP). (PubMed, Ann Endocrinol (Paris))
Conformal or stereotactic radiotherapy may be discussed on a case-by-case basis, especially in case of drug inefficacy or poor tolerance. Acromegaly should be managed by a multidisciplinary team, preferably within an expert center such as a reference or skill center for rare pituitary diseases.
Clinical guideline
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
|
Signifor (pasireotide)
over1year
Adrenal Cell Carcinoma Presenting With Post-menopausal Bleeding And IGF-2 Induced Hypoglycaemia (ENDO 2023)
A subsequent CT adrenals demonstrated a 12.8 x 13.2 x 10.6cm left adrenal mass and she failed a 1mg overnight dexamethasone suppression test. This is a rare case of ACC secreting multiple hormones, resulting in post-menopausal bleeding and IGF-2 mediated hypoglycaemia.
Late-breaking abstract
|
IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2)
|
IGF1 elevation • IGF2 elevation
|
dexamethasone • Lysodren (mitotane)
over1year
A Rare Case Of Igf-2 Induced Hypoglycemia Associated With Metastatic Colon Cancer. (ENDO 2023)
Case description: A 66-year-old man with a history of stage IV colon cancer presented to the hospital due to breathlessness while receiving chemotherapy (Bevacizumab plus FOLFOX4)...Dexamethasone 10 mg daily was started, and BG were maintained > 70mg/dl without dextrose infusion...Neoadjuvant therapies such as radiation and chemotherapy may reduce occurrences of hypoglycemia, but only temporarily. Glucocorticoids may be used when the underlying malignancy cannot be treated.
Clinical • Late-breaking abstract • Metastases
|
IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2)
|
IGF1 elevation • IGF2 elevation
|
Avastin (bevacizumab) • dexamethasone
over1year
A Rare Unusual Plurihormonal Pituitary Neuroendocrine Tumor with Multi-lineage Differentiation Presenting in a Patient with Acromegaly (AANP 2023)
Descriptions of this rare tumor are limited to case reports; its pathogenesis is not well understood, though it has been posited they represent a stem cell tumor with multilineage differentiation. The purpose of this report is to raise awareness of this subtype and encourage a comprehensive immunohistochemical workup for accurate classification of PitNETs.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
over1year
Insulin-like Growth Factor-1 (IGF-1) Related Drugs in Pain Management. (PubMed, Pharmaceuticals (Basel))
Conclusions. This review highlights the potential of IGF-1 and IGF-1R inhibitors in pain management, but further research is needed to fully understand their efficacy and potential side effects.
Review • Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
over1year
Metformin sensitises osteosarcoma to chemotherapy via the IGF-1R/miR-610/FEN1 pathway. (PubMed, Eur J Histochem)
Furthermore, metformin was observed to enhance adriamycin's effects in a murine xenograft model. Metformin enhanced OS cell sensitivity to cytotoxic agents via the IGF-1R/miR-610/FEN1 signalling axis, highlighting its potential as an adjuvant during chemotherapy.
Journal
|
FEN1 (Flap Structure-Specific Endonuclease 1)
|
IGF1 elevation
|
doxorubicin hydrochloride • metformin
over1year
A Rare Case of Coexisting Acromegaly and Adrenal Cushing's Syndrome (ENDO 2023)
Repeat 24h urine cortisol and midnight salivary cortisol levels were elevated; dexamethasone suppression test was positive... This case highlights the rare coexistence of acromegaly and adrenal Cushing's disease in a 50 year old woman. Though the relationship between acromegaly and cancer has been historically controversial, more recent studies have shown an increased risk of both benign and malignant tumors with acromegaly. Untreated Cushing's Disease has been associated with mildly elevated IGF1 which then decreases after remission; it is unclear if the same pathological process is involved in other etiologies of hypercortisolemia like adrenal Cushing's syndrome, but re-evaluation of IGF1 after treatment of Cushing's should be considered.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
|
dexamethasone
over1year
A Case of Mixed Growth Hormone and Prolactin-secreting Giant Pituitary Macroadenoma (ENDO 2023)
Patient was started on low dose cabergoline in caution of prevention of possibility of rapid response-related significant volume contraction of the tumor with possibility of reactive edema...Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*
Clinical
|
SSTR (Somatostatin Receptor) • IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
over1year
Diagnostic and management challenges in a patient with a giant pituitary lactosomatotroph adenoma (ENDO 2023)
He commenced on low dose cabergoline (0.5mg/week) and two months later clinical improvement was noted, accompanied by a marked reduction of prolactin (830ng/mL) and tumor shrinkage... The differential diagnosis of large skull base tumors, particularly those affecting sellar/clival regions, must always include prolactinoma, hence serum prolactin should be measured keeping in mind the possible occurrence of hook effect. Most giant prolactinomas respond to dopamine agonists, which should be considered as a first-line therapy, with marked reductions in both prolactin and tumor size often seen within the first weeks of treatment. GH-cosecretion may also ameliorate/normalize with dopamine agonists.
Clinical
|
IGF1 (Insulin-like growth factor 1) • PRL (Prolactin)
|
IGF1 elevation
over1year
Hyperthyroidism and Acromegaly in a Patient with a Mature Plurihormonal PIT1 Lineage PitNET/adenoma (ENDO 2023)
Discharge medications were hydrocortisone 10 mg AM and, 5 mg early afternoon and levothyroxine 50 mcg daily. This case demonstrates the potential for PitNETs to secrete multiple biologically active pituitary hormones, including prolactin, TSH and GH, highlighting the importance of maintaining an index of suspicion for pituitary causes in the evaluation of thyrotoxicosis and of considering the plurihormonal potential of PitNETs in patients presenting with multiple endocrinopathies.*Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
over1year
Novel Approach To Management of Acromegaly with De Novo Oral Octreotide Or Combination Therapy with Cabergoline: A Case Series (ENDO 2023)
First line medical therapy consists of first-generation injectable somatostatin receptor ligands (SRL) (octreotide LAR, lanreotide autogel)...If IGF-1 levels do not normalize, pasireotide or pegvisomant can be tried...Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*
Clinical • Combination therapy
|
SSTR (Somatostatin Receptor) • IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
|
Somatuline Depot (lanreotide prolonged-release subcutaneous) • Signifor (pasireotide) • octreotide acetate
over1year
A Rare Case of Emergent Orthotopic Heart Transplantation for Cardiogenic Shock in a Patient With Undiagnosed Acromegaly. (ENDO 2023)
He was then started on octreotide 50 mcg TID and eventually transitioned to Sandostatin depot 20 mg intergluteal injection every 4 weeks... Acromegaly is often missed due to the insidious onset of physical changes that are observed. Literature review reveals only two other cases of acromegaly related NICM resulting in cardiogenic shock, in which only one patient received an emergent heart transplant. When recognized early, patients can be treated surgically and or/medically before irreversible changes occur.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
|
octreotide acetate solution for injection
over1year
Isosexual peudo-precocious puberty due to Leydig cell tumor in a prepubertal child (ENDO 2023)
We present a case of a testicular Leydig cell tumor that presented as peripheral precocious puberty marked by low gonadotropins and elevated testosterone with ultrasound findings of a vascular mass with testicular artery feeding branch in the periphery. Early detection of a Leydig cell tumor is crucial as it can be treated by enucleation thus salvaging the testes.*Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins.
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
over1year
Sparse granulation in growth hormone secreting adenomas: Clinical implications of a rare histological finding (ENDO 2023)
Patient is waiting for a second surgery via craniotomy and, given the SG finding on histology, pasireotide therapy will be offered...Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*
Clinical
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation
|
Signifor (pasireotide)
over1year
Sawtooth Hypoglycemia: Rare Case Of IGF-2 Mediated Hypoglycemia With Elevated Proinsulin Level and "Sawtooth" Pattern on CGMS (ENDO 2023)
The patient was admitted to the ICU and IV dextrose was initiated.As Liposarcomas are known to be associated with Non-islet cell tumor hypoglycemia (NICTH), treatment with Prednisone was started... Proinsulin level is usually suppressed in IGF-2 mediated hypoglycemia. Our case is unusually associated with high Proinsulin level. One hypothesis is the possible structural similarities leading to lab assay interactions between Proinsulin and "Pro-IGF-2", which is thought to be one of the main molecules responsible for hypoglycemia in this condition.
Clinical
|
IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2)
|
IGF1 elevation
|
prednisone
over1year
A Unique Case of IGF-2 Induced Hypoglycemia as first Manifestation of Hepatocellular Carcinoma (ENDO 2023)
Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*
Clinical
|
IGF1 (Insulin-like growth factor 1) • IGF2 (Insulin-like growth factor 2) • IR (Insulin receptor)
|
IGF1 elevation • IGF2 elevation • Albumin-L
over1year
Mutual connected IL-6, EGFR and LIN28/Let7-related mechanisms modulate PD-L1 and IGF upregulation in HNSCC using immunotherapy. (PubMed, Front Oncol)
Furthermore, the LIN28-Let7 axis mediates the NF-κB-IL-6-STAT3 amplification loop, activated LIN28-Let7 axis up-regulates RAS, AKT, IL-6, IGF-1/2, IGF-1R, Myc, and PD-L1, plays pivotal roles in IGF-1R activation and Myc, NF-κB, STAT3 concomitant activation. Therefore, based on a detailed mechanisms review, our article firstly reveals that IL-6, EGFR, and LIN28/Let7-related mechanisms mediate PD-L1 and IGF upregulation in HNSCC, which comprehensively influences immunity, inflammation, metabolism, and metastasis in the tumor microenvironment, and might be fundamental for overcoming therapy resistance.
Review • Journal • PD(L)-1 Biomarker • IO biomarker
|
EGFR (Epidermal growth factor receptor) • IL6 (Interleukin 6) • JAK1 (Janus Kinase 1) • STAT3 (Signal Transducer And Activator Of Transcription 3) • IGF1 (Insulin-like growth factor 1) • RAC1 (Rac Family Small GTPase 1) • SOX2 • IRS1 (Insulin Receptor Substrate 1) • IL6R (Interleukin 6 receptor) • TP63 (Tumor protein 63) • IGFBP3 (Insulin-like growth factor binding protein 3) • CCAT1 (Colon Cancer Associated Transcript 1)
|
PD-L1 expression • EGFR expression • IGF1 elevation • IGFBP3 elevation • IL6 expression • TAp63 overexpression
over1year
Association between metabolic syndrome, insulin resistance, and IGF-1 in breast cancer survivors of DIANA-5 study. (PubMed, J Cancer Res Clin Oncol)
These results could have important clinical implications for planning customized strategies aimed at modulating IGF-1 levels in BC survivors. In fact, while the IGF-1 system seems to be much more compromised in subjects with a diagnosis of MetS, in noMetS subjects, IGF-1 levels could better respond to lifestyle changes.
Journal
|
IGF1 (Insulin-like growth factor 1)
|
IGF1 elevation